10X Genomics (TXG) PT Raised to $47 at Piper Sandler
Tweet
Share
E-mailGet Alerts TXG Hot Sheet
Price: $58.30 +0.95%
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
7 Buy, 11 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
Piper Sandler analyst David Westenberg raised the price target on 10X Genomics (NASDAQ: TXG) to $47.00 (from $42.00) while maintaining a Neutral rating.
You May Also Be Interested In
- 10X Genomics (TXG) PT Raised to $65 at Stephens
- Macquarie Upgrades Inventec Corp (2356:TT) to Neutral
- Tingyi Cayman Islands Holding Corp. (322:HK) (TCYMY) PT Raised to HK$11.60 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
